Hahn-Schickard is growing in leaps and bounds. With a total of 270 employees at the four locations including Stuttgart, Villingen-Schwenningen, Freiburg and Ulm, Hahn-Schickard covers a multitude of different application areas with its competence in the field of microsystems engineering. The area of bioanalytical assay development has expanded particularly dynamically in recent years, driven forward significantly by Prof. Dr. Felix von Stetten. Adding von Stetten to the board of the now five Hahn-Schickard Institute directors (previously Prof. Alfons Dehé, Prof. Yiannos Manoli, Prof. Roland Zengerle and Prof. André Zimmermann) on December 1, 2020 will continue to expand this field with great momentum.
The Hahn-Schickard Institute of Microanalysis Systems, that up to now had been headed by the physicist Prof. Dr.-Ing. Roland Zengerle, can point to many success stories with numerous technology transfers from research put into practice. The most recent example is the spin off company Spindiag in 2016 that launched a lab-quality corona rapid test in November 2020.
In 2008, von Stetten joined Hahn-Schickard as Head of Division and, together with his team, strongly promoted the development of such molecular diagnostic on-site tests. The associated growth led to the founding of the Hahn-Schickard Institute of Microanalysis Systems in Freiburg in 2016. Summarizing his goals, von Stetten stated, “I am now looking forward to contributing my specific experience in bioanalytical issues to the management board and to opening up further future perspectives.”
Von Stetten is currently working on the vision of so-called molecularly integrated test systems. These are tests that no longer require the sequential pipetting of liquids, since all reactions can run virtually side by side in a miniaturized reaction chamber. For von Stetten, the transfer into practical applications, into mobile test systems for personalized diagnostics as well as food and environmental analysis, is also at the forefront of these developments.Back